Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPBWR1 | P48145 | 11/20 | 0.65 |
| ▸ | GLP1R | P43220 | 6/20 | 0.62 |
| ▸ | CCKBR | P32239 | 3/20 | 0.60 |
| ▸ | CCKAR | P32238 | 1/20 | 0.60 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26080267 | 1.00 | NPBWR1 (0.65) | NPBWR1GLP1RCCKBRCCKAROPRD1 | |
| SCHEMBL26080270 | 0.99 | NPBWR1 (0.64) | NPBWR1GLP1RCCKBRCCKAROPRD1 | |
| SCHEMBL26080292 | 0.99 | NPBWR1 (0.64) | NPBWR1GLP1RCCKBRCCKAROPRD1 | |
| SCHEMBL26080264 | 0.98 | NPBWR1 (0.63) | NPBWR1GLP1RCCKBRCCKAROPRD1 | |
| SCHEMBL26080277 | 0.98 | NPBWR1 (0.63) | NPBWR1GLP1RCCKBRCCKAROPRD1 | |
| SCHEMBL26080268 | 0.98 | NPBWR1 (0.63) | NPBWR1GLP1RCCKBRCCKAROPRD1 | |
| SCHEMBL26080274 | 0.98 | NPBWR1 (0.63) | NPBWR1GLP1RCCKBRCCKAROPRD1 | |
| SCHEMBL26080285 | 0.98 | NPBWR1 (0.64) | NPBWR1GLP1RCCKBRCCKAROPRD1 | |
| SCHEMBL26080280 | 0.97 | NPBWR1 (0.61) | NPBWR1GLP1RCCKBRCCKAROPRD1 | |
| SCHEMBL26080286 | 0.97 | NPBWR1 (0.64) | NPBWR1GLP1RCCKBRCCKAROPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230312650-A1 | Antifungal Peptides, Compounds Including The Same, And Methods Of Use Thereof | SETON HALL UNIVERSITY (US) | 2023-10-05 | — | — | US | disclosed |
| US-20230312650-A1 | Antifungal Peptides, Compounds Including The Same, And Methods Of Use Thereof | SETON HALL UNIVERSITY (US) | 2023-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312650-A1 | Antifungal Peptides, Compounds Including The Same, And Methods Of Use Thereof | ARF5, CDC5L, API5 | NPBWR1 3187/4885GLP1R 3720/4885CCKBR 4885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.